Literature DB >> 16236034

Prescribing statins.

J K Aronson.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16236034      PMCID： PMC1884938          DOI： 10.1111/j.1365-2125.2005.02521.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Over-the-counter medicines.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

2.  Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands.

Authors:  Aukje K Mantel-Teeuwisse; W M Monique Verschuren; Olaf H Klungel; Anthonius de Boer; Daan Kromhout
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

3.  Rational prescribing, appropriate prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

4.  Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.

Authors:  Jeffrey K Aronson
Journal:  J Eval Clin Pract       Date:  2005-04       Impact factor: 2.431

5.  The polypill and cardiovascular disease.

Authors:  Tom Fahey; Peter Brindle; Shah Ebrahim
Journal:  BMJ       Date:  2005-05-07

6.  Suboptimal choices and dosing of statins at start of therapy.

Authors:  Aukje K Mantel-Teeuwisse; Olaf H Klungel; Tom Schalekamp; W M Monique Verschuren; Arijan J Porsius; Anthonius de Boer
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

7.  Synvinolin in hypercholesterolaemia.

Authors:  A G Olsson; J Mölgaard; H von Schenk
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

8.  Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.

Authors:  Reimar W Thomsen; Søren P Johnsen; Anne V Olesen; Jens T Mortensen; Henrik Bøggild; Jørn Olsen; Henrik T Sørensen
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

9.  Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.

Authors:  T Walley; P Folino-Gallo; P Stephens; E Van Ganse
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

10.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28
View more
  5 in total

1.  A prescription for better prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

2.  A prescription for better prescribing.

Authors:  Jeffrey K Aronson; Graeme Henderson; David J Webb; Michael D Rawlins
Journal:  BMJ       Date:  2006-09-02

3.  Balanced prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-12       Impact factor: 4.335

Review 4.  Chairman of the Joint Formulary Committee, British National Formulary.

Authors:  Martin Kendall
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

5.  Good prescribing: better systems and prescribers needed.

Authors:  Simon Maxwell
Journal:  CMAJ       Date:  2010-03-08       Impact factor: 8.262
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.